bucladesine has been researched along with Respiratory Distress Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP | 1 |
Chiang, CH; Hsu, CS; Hsu, K; Huang, KL; Wang, D | 1 |
2 other study(ies) available for bucladesine and Respiratory Distress Syndrome
Article | Year |
---|---|
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1996 |
Dibutyryl cAMP prevents increased vascular permeability caused by air embolism in isolated rat lungs.
Topics: Aerospace Medicine; Aminophylline; Animals; Bronchodilator Agents; Bucladesine; Capillary Permeability; Drug Evaluation, Preclinical; Embolism, Air; Extravehicular Activity; In Vitro Techniques; Lung; Male; Pentoxifylline; Pulmonary Wedge Pressure; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Time Factors; Vasodilator Agents | 1997 |